Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May-Jun;15(3):e1597.
doi: 10.1002/wsbm.1597. Epub 2023 Jan 12.

The role of STING signaling in central nervous system infection and neuroinflammatory disease

Affiliations
Review

The role of STING signaling in central nervous system infection and neuroinflammatory disease

Lauren E Fritsch et al. WIREs Mech Dis. 2023 May-Jun.

Abstract

The cyclic guanosine monophosphate-adenosine monophosphate (GMP-AMP) synthase-Stimulator of Interferon Genes (cGAS-STING) pathway is a critical innate immune mechanism for detecting the presence of double-stranded DNA (dsDNA) and prompting a robust immune response. Canonical cGAS-STING activation occurs when cGAS, a predominantly cytosolic pattern recognition receptor, binds microbial DNA to promote STING activation. Upon STING activation, transcription factors enter the nucleus to cause the production of Type I interferons, inflammatory cytokines whose primary function is to prime the host for viral infection by producing a number of antiviral interferon-stimulated genes. While the pathway was originally described in viral infection, more recent studies have implicated cGAS-STING signaling in a number of different contexts, including autoimmune disease, cancer, injury, and neuroinflammatory disease. This review focuses on how our understanding of the cGAS-STING pathway has evolved over time with an emphasis on the role of STING-mediated neuroinflammation and infection in the nervous system. We discuss recent findings on how STING signaling contributes to the pathology of pain, traumatic brain injury, and stroke, as well as how mitochondrial DNA may promote STING activation in common neurodegenerative diseases. We conclude by commenting on the current knowledge gaps that should be filled before STING can be an effective therapeutic target in neuroinflammatory disease. This article is categorized under: Neurological Diseases > Molecular and Cellular Physiology Infectious Diseases > Molecular and Cellular Physiology Immune System Diseases > Molecular and Cellular Physiology.

Keywords: STING; brain injury; cGAS; interferons; neuroinflammation; stroke.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Mechanism of cGAS-STING signaling. Possible triggers for cGAS-STING signaling discussed in this review are boxed in light blue. DNA binds to cGAS to facilitate dimerization to produce cyclic dinucleotide 2′,3′-cyclic GMP–AMP (2′,3′-cGAMP). cGAMP binds to STING which promotes its dimerization/oligomerization. COP-II vesicles transport STING to the Golgi to activate TBK1. Dimerized TBK1 then phosphorylates IRF3 for nuclear translocation for the transcription of IFN-responsive genes. Created with BioRender.com
FIGURE 2
FIGURE 2
Following a stroke or TBI, cGAS-STING signaling in resident microglia is activated, likely at least in part due to the presence of mitochondrial DNA. Microglia subsequently produce interferons (primarily IFNβ) and chemokines that result in the infiltration of peripheral immune cells. Once present, these immune cells are also activated and produce additional interferons. Interferons produced by all cell types can bind both their own and other cells’ IFN receptors, IFNAR, including neurons and astrocytes, resulting in increased IFN signaling. Created with BioRender.com

Similar articles

Cited by

References

    1. Abdullah A, Zhang M, Frugier T, Bedoui S, Taylor JM, & Crack PJ (2018). STING-mediated type-I interferons contribute to the neuroinflammatory process and detrimental effects following traumatic brain injury. Journal of Neuroinflammation, 15, 323. 10.1186/s12974-018-1354-7 - DOI - PMC - PubMed
    1. Ablasser A, Goldeck M, Cavlar T, Deimling T, Witte G, Röhl I, Hopfner K-P, Ludwig J, & Hornung V (2013). CGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING. Nature, 498(7454), 380–384. 10.1038/nature12306 - DOI - PMC - PubMed
    1. Alexopoulou A, Vasilieva L, & Karayiannis P (2020). New approaches to the treatment of chronic hepatitis B. Journal of Clinical Medicine, 9(10), 3187. 10.3390/jcm9103187 - DOI - PMC - PubMed
    1. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, & Young IG (1981). Sequence and organization of the human mitochondrial genome. Nature, 290(5806), 457–465. 10.1038/290457a0 - DOI - PubMed
    1. Andreeva L, Hiller B, Kostrewa D, Lässig C, de Oliveira Mann CC, Jan Drexler D, Maiser A, Gaidt M, Leonhardt H, Hornung V, & Hopfner K-P (2017). CGAS senses long and HMGB/TFAM-bound U-turn DNA by forming protein-DNA ladders. Nature, 549(7672), 394–398. 10.1038/nature23890 - DOI - PubMed

FURTHER READING

    1. Ma F, Li B, Yu Y, Iyer SS, Sun M, & Cheng G (2015). Positive feedback regulation of type I interferon by the interferon-stimulated gene STING. EMBO Reports, 16(2), 202–212. 10.15252/embr.201439366 - DOI - PMC - PubMed

Publication types